Auteurs Hamerstehl A, Gadiollet É, Martel A, Groulier A, Aloi D, Nguyen AM, Lassalle S, Bertolotto C, Caujolle JP, Maschi C, Ducoulombier A, Mathis T, Baillif S, Nahon-Estève S
Journal francais d'ophtalmologie Nov 2024
Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 2023.Auteurs Seedor RS, Aplin AE, Bertolotto C, Carvajal RD, Deacon N, Doble K, Hamid O, Haq R, Kadosh M, Khan S, Kraska J, Lutzky J, McKean M, Montazeri K, Moser J, Onken M, Orloff M, Sacco JJ, Smalley K, Selig SM
Pigment cell & melanoma research Oct 2024
Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.Auteurs Proteau S, Krossa I, Husser C, Guéguinou M, Sella F, Bille K, Irondelle M, Dalmasso M, Barouillet T, Cheli Y, Pisibon C, Arrighi N, Nahon-Estève S, Martel A, Gastaud L, Lassalle S, Mignen O, Brest P, Mazure NM, Bost F, Baillif S, Landreville S, Turcotte S, Hasson D, Carcamo S, Vandier C, Bernstein E, Yvan-Charvet L, Levesque MP, Ballotti R, Bertolotto C, Strub T
EMBO molecular medicine Aug 2024
Loss of LYN is frequent in targeted-therapy resistant melanoma cells and favors metastatic properties.Auteurs Gaudel C, Pisibon C, Soysouvanh F, Giuliano S, Picard-Gauci A, Leclerc J, Hofman P, Bahadoran P, Bertolotto C, Ballotti R
The Journal of investigative dermatology Jul 2024
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.Auteurs Di Leo L, Pagliuca C, Kishk A, Rizza S, Tsiavou C, Pecorari C, Dahl C, Pacheco MP, Tholstrup R, Brewer JR, Berico P, Hernando E, Cecconi F, Ballotti R, Bertolotto C, Filomeni G, Gjerstorff MF, Sauter T, Lovat P, Guldberg P, De Zio D
Proceedings of the National Academy of Sciences of the United States of America Jun 2024
Messing with cancer therapy: how the melanoma phenotype predicts checkpoint inhibitor response.Auteurs Meierjohann S, Bertolotto C
Signal transduction and targeted therapy Apr 2024
[When ubiquitination intertwines with cutaneous melanoma: a mechanism to explore].Auteurs Arrighi N, Breda L, Kerdilès T, Meyer C, Prugneau L, Rabatel O, Wagner G, Krossa I, Pisibon C
Medecine sciences : M/S Mar 2024
[PROTAC technology: a promising approach in oncology].Auteurs Azuaga Moreso M, Bertrand C, Duffrene J, Dumont M, Lecouffe A, Muller C, Arrighi N, Onesto C
Medecine sciences : M/S Mar 2024
[Trained immunity : emerging strategies against antibiotic resistance].Auteurs Badin L, Franc C, Gilbert P, Magdeleine JJ, Martin L, Vernaz R, Arrighi N, Garcia-Sanchez JA
Medecine sciences : M/S Mar 2024
Mechanisms of melanoma aggressiveness with age.Auteurs Bertolotto C
Nature aging Mar 2024